Organism showing marked resistance to multidrug therapy is
**Core Concept**
The question pertains to antibiotic resistance in bacteria, specifically the emergence of strains that defy treatment with multiple drugs. This phenomenon is a significant concern in clinical microbiology, as it compromises the efficacy of standard antimicrobial therapies.
**Why the Correct Answer is Right**
Mycobacterium tuberculosis (MTB) is notorious for its ability to develop resistance to a wide range of antimicrobial agents, including isoniazid, rifampicin, and ethambutol. This resistance is often due to chromosomal mutations in genes encoding drug targets, such as the katG gene responsible for isoniazid activation. The presence of these mutations can render MTB strains resistant to multiple drugs, making them challenging to treat. In addition, MTB's slow growth rate and unique cell wall structure contribute to its ability to withstand antimicrobial agents.
**Why Each Wrong Option is Incorrect**
**Option A:** While Staphylococcus aureus is a notorious antibiotic-resistant pathogen, its resistance profile is generally limited to a few specific antimicrobial agents, such as methicillin and vancomycin. It is not typically associated with marked resistance to multidrug therapy.
**Option B:** Escherichia coli (E. coli) is a common cause of urinary tract infections and can exhibit resistance to various antibiotics, including beta-lactams and fluoroquinolones. However, its resistance profile is generally not as complex or extensive as that of M. tuberculosis.
**Option C:** Pseudomonas aeruginosa is a highly adaptable and resistant bacterium, but its resistance profile is typically limited to a few specific antimicrobial agents, such as carbapenems and aminoglycosides. While it can exhibit resistance to multiple drugs, it is not as notorious for multidrug resistance as M. tuberculosis.
**Option D:** Klebsiella pneumoniae can exhibit resistance to various antibiotics, including carbapenems and cephalosporins. However, its resistance profile is generally not as complex or extensive as that of M. tuberculosis.
**Clinical Pearl / High-Yield Fact**
Mycobacterium tuberculosis's ability to develop resistance to multiple drugs is a major public health concern, particularly in regions with high TB prevalence. Clinicians should be aware of the emergence of drug-resistant strains and adhere to standard treatment guidelines to prevent the spread of resistance.
**Correct Answer:** C. Pseudomonas aeruginosa.